Clinical Trial Update: Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 multiple IV dose study of PF-04360365 in patients with mild to moderate Alzheimer's disease has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PF-04360365

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-11-07